BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29653141)

  • 1. Dual mechanism of type VII collagen transfer by bone marrow mesenchymal stem cell extracellular vesicles to recessive dystrophic epidermolysis bullosa fibroblasts.
    McBride JD; Rodriguez-Menocal L; Candanedo A; Guzman W; Garcia-Contreras M; Badiavas EV
    Biochimie; 2018 Dec; 155():50-58. PubMed ID: 29653141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft.
    Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y
    J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment.
    Riedl J; Pickett-Leonard M; Eide C; Kluth MA; Ganss C; Frank NY; Frank MH; Ebens CL; Tolar J
    Stem Cells; 2021 Jul; 39(7):897-903. PubMed ID: 33609408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
    Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder.
    Alexeev V; Uitto J; Igoucheva O
    Cytotherapy; 2011 Jan; 13(1):30-45. PubMed ID: 20854215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
    J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
    Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
    JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
    Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
    J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa.
    Perdoni C; McGrath JA; Tolar J
    Stem Cell Res Ther; 2014 Nov; 5(6):121. PubMed ID: 25376815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
    Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
    Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
    Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
    J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-Modified Blister Fluid-Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa.
    Kikuchi Y; Tamakoshi T; Ishida R; Kobayashi R; Mori S; Ishida-Yamamoto A; Fujimoto M; Kaneda Y; Tamai K
    J Invest Dermatol; 2023 Dec; 143(12):2447-2455.e8. PubMed ID: 37302620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts.
    Atanasova VS; Russell RJ; Webster TG; Cao Q; Agarwal P; Lim YZ; Krishnan S; Fuentes I; Guttmann-Gruber C; McGrath JA; Salas-Alanis JC; Fertala A; South AP
    J Invest Dermatol; 2019 Jul; 139(7):1497-1505.e5. PubMed ID: 30684555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
    Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
    Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
    Aguado T; García M; García A; Ferrer-Mayorga G; Martínez-Santamaría L; Del Río M; Botella LM; Sánchez-Puelles JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.
    Conget P; Rodriguez F; Kramer S; Allers C; Simon V; Palisson F; Gonzalez S; Yubero MJ
    Cytotherapy; 2010 May; 12(3):429-31. PubMed ID: 20230217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras.
    Petrova A; Georgiadis C; Fleck RA; Allison L; McGrath JA; Dazzi F; Di WL; Qasim W
    J Invest Dermatol; 2020 Jan; 140(1):121-131.e6. PubMed ID: 31326396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.